CHELSEA CASTELLONE: Open Payments
NPI 1639551799 · NINETY SIX, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 55 payments from 21 companies in 2025. Trend: 2023 $365 · 2024 $447 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $158 |
| Lilly USA, LLC | 10 | $127 |
| Exact Sciences Corporation | 5 | $96 |
| PFIZER INC. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Philips North America LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| ABBVIE INC. | 1 | $31 |
Products named: Ozempic, MOUNJARO, The Cologuard Plus Collection Kit, NURTEC ODT, JARDIANCE, Vest Therapy Und, Rybelsus, GEMTESA.
Industry payments across SC — which companies pay providers there.
